Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Biliary Tract Diseases

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    March 2024
  1. XIN HY, Zou JX, Sun RQ, Hu ZQ, et al
    Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2024 Mar 10. doi: 10.1007/s00535-024-02090.
    PubMed     Abstract available


    October 2023
  2. WU JF, Peng SS, Tai CS, Lin WH, et al
    The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia.
    J Gastroenterol. 2023 Oct 30. doi: 10.1007/s00535-023-02051.
    PubMed     Abstract available


  3. WANG H, Li Y, Pu X, Liang X, et al
    MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis.
    J Gastroenterol. 2023 Oct 16. doi: 10.1007/s00535-023-02045.
    PubMed     Abstract available


    September 2023
  4. OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al
    Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers.
    J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037.
    PubMed     Abstract available


    July 2023
  5. FUJITA N, Yasuda I, Endo I, Isayama H, et al
    Evidence-based clinical practice guidelines for cholelithiasis 2021.
    J Gastroenterol. 2023 Jul 15. doi: 10.1007/s00535-023-02014.
    PubMed     Abstract available


  6. PENG M, Li H, Cao H, Huang Y, et al
    Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2023 Jul 11. doi: 10.1007/s00535-023-02012.
    PubMed     Abstract available


    June 2023
  7. XU H, Lin X, Li Z, He X, et al
    VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
    J Gastroenterol. 2023 Jun 30. doi: 10.1007/s00535-023-02015.
    PubMed     Abstract available


  8. YOSHIDA H, Shiokawa M, Kuwada T, Muramoto Y, et al
    Anti-integrin alphavbeta6 autoantibodies in patients with primary sclerosing cholangitis.
    J Gastroenterol. 2023 Jun 13. doi: 10.1007/s00535-023-02006.
    PubMed     Abstract available


    May 2023
  9. KIM KA, Choi HY, Ki M, Jang ES, et al
    Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019.
    J Gastroenterol. 2023 May 17. doi: 10.1007/s00535-023-01999.
    PubMed     Abstract available


    December 2022
  10. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Dec 23. doi: 10.1007/s00535-022-01944.
    PubMed    


    September 2022
  11. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    PubMed     Abstract available


  12. ARIZUMI T, Tazuma S, Isayama H, Nakazawa T, et al
    Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis.
    J Gastroenterol. 2022 Sep 6. pii: 10.1007/s00535-022-01914.
    PubMed     Abstract available


    July 2022
  13. KODAMA K, Kawaoka T, Kosaka M, Johira Y, et al
    Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
    J Gastroenterol. 2022 Jul 18. pii: 10.1007/s00535-022-01887.
    PubMed     Abstract available


    June 2022
  14. MULLIRI A, Menahem B, Alves A, Dupont B, et al
    Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    J Gastroenterol. 2022 Jun 15. pii: 10.1007/s00535-022-01886.
    PubMed     Abstract available


    April 2022
  15. MORI Y, Okawara M, Fujimoto K, Oba T, et al
    Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan.
    J Gastroenterol. 2022 Apr 12. pii: 10.1007/s00535-022-01873.
    PubMed     Abstract available


    March 2022
  16. SUZUKI Y, Mori T, Momose H, Matsuki R, et al
    Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
    J Gastroenterol. 2022 Mar 31. pii: 10.1007/s00535-022-01868.
    PubMed     Abstract available


  17. ISAYAMA H, Tazuma S, Kokudo N, Tanaka A, et al
    Correction to: Clinical guidelines for primary sclerosing cholangitis 2017.
    J Gastroenterol. 2022 Mar 16. pii: 10.1007/s00535-022-01867.
    PubMed    


    December 2021
  18. BURGHART L, Halilbasic E, Schwabl P, Simbrunner B, et al
    Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
    J Gastroenterol. 2021 Dec 11. pii: 10.1007/s00535-021-01839.
    PubMed     Abstract available


    November 2021
  19. MATSUMOTO K, Ohfuji S, Abe M, Komori A, et al
    Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study.
    J Gastroenterol. 2021 Nov 18. pii: 10.1007/s00535-021-01836.
    PubMed     Abstract available


    December 2020
  20. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Dec 30. pii: 10.1007/s00535-020-01755.
    PubMed    


    October 2020
  21. MARUKI Y, Morizane C, Arai Y, Ikeda M, et al
    Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    J Gastroenterol. 2020 Oct 26. pii: 10.1007/s00535-020-01735.
    PubMed     Abstract available


  22. YU WL, Yu G, Dong H, Chen K, et al
    Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
    J Gastroenterol. 2020 Oct 21. pii: 10.1007/s00535-020-01729.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.